Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A YAC-based physical map of the mouse genome.
Nusbaum C, Slonim DK, Harris KL, Birren BW, Steen RG, Stein LD, Miller J, Dietrich WF, Nahf R, Wang V, Merport O, Castle AB, Husain Z, Farino G, Gray D, Anderson MO, Devine R, Horton LT Jr, Ye W, Wu X, Kouyoumjian V, Zemsteva IS, Wu Y, Collymore AJ, Courtney DF, Tam J, Cadman M, Haynes AR, Heuston C, Marsland T, Southwell A, Trickett P, Strivens MA, Ross MT, Makalowski W, Xu Y, Boguski MS, Carter NP, Denny P, Brown SD, Hudson TJ, Lander ES. Nusbaum C, et al. Among authors: marsland t. Nat Genet. 1999 Aug;22(4):388-93. doi: 10.1038/11967. Nat Genet. 1999. PMID: 10431246
New Landscape: Physician Compensation.
Thomas CA, Hirschorn AM, Tomkins JE, Birch WE, Bosserman LD, Patt DA, Patel DR, Diaz M, Marsland TA, Klix MM, Balaban EP, Blanchard EM, Franklin GE, Seth R, Norden A. Thomas CA, et al. Among authors: marsland ta. JCO Oncol Pract. 2021 Apr;17(4):186-189. doi: 10.1200/OP.20.00788. Epub 2020 Dec 22. JCO Oncol Pract. 2021. PMID: 33351676 No abstract available.
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).
Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Marsland T, Patel T, Rubin M, White L, Yang JC, Klughammer B, Colburn D, Miller V, Johnson BE. Kabbinavar F, et al. Among authors: marsland t. J Thorac Oncol. 2014 Sep;9(9):1411-7. doi: 10.1097/JTO.0000000000000274. J Thorac Oncol. 2014. PMID: 25122437 Free article. Clinical Trial.
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report.
AVBCC 2013 Steering Committee: Co-Chairs; Zweigenhaft B, Bosserman L, Kenney JT Jr, Lawless GD, Marsland TA, Deligdish CK, Burgoyne DS, Knopf KB, Long DM, McKercher P, Owens GM, Hennessy JE, Lang JR, Malin J, Natelson L, Palmgren MC, Slotnik J, Shockney LD, Vogenberg FR. AVBCC 2013 Steering Committee: Co-Chairs, et al. Among authors: marsland ta. Am Health Drug Benefits. 2013 Jul;6(5):236-46. Am Health Drug Benefits. 2013. PMID: 24991360 Free PMC article.
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.
Johnson BE, Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Lin CY, Marsland T, Patel T, Polikoff J, Rubin M, White L, Yang JC, Bowden C, Miller V. Johnson BE, et al. Among authors: marsland t. J Clin Oncol. 2013 Nov 1;31(31):3926-34. doi: 10.1200/JCO.2012.47.3983. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101054 Clinical Trial.
Lung cancer screening: a new era.
Marsland TA, Wells JW. Marsland TA, et al. Oncology (Williston Park). 2012 Feb;26(2):190-1. Oncology (Williston Park). 2012. PMID: 22489355 Free article. No abstract available.
37 results